SI1960428T1 - Protitelesa proti amiloidu beta z glikoziliranjem v variabilni regiji - Google Patents

Protitelesa proti amiloidu beta z glikoziliranjem v variabilni regiji

Info

Publication number
SI1960428T1
SI1960428T1 SI200631096T SI200631096T SI1960428T1 SI 1960428 T1 SI1960428 T1 SI 1960428T1 SI 200631096 T SI200631096 T SI 200631096T SI 200631096 T SI200631096 T SI 200631096T SI 1960428 T1 SI1960428 T1 SI 1960428T1
Authority
SI
Slovenia
Prior art keywords
glycosylation
variable region
antibodies against
amyloid beta
against amyloid
Prior art date
Application number
SI200631096T
Other languages
English (en)
Inventor
Hansruedi Loetscher
Walter Huber
Diana Schuhbauer
Karl Weyer
Manfred Brockhaus
Bernd Bohrmann
Hans Koll
Andreas Schaubmar
Kurt Lang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SI1960428T1 publication Critical patent/SI1960428T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
SI200631096T 2005-12-12 2006-12-11 Protitelesa proti amiloidu beta z glikoziliranjem v variabilni regiji SI1960428T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05027090 2005-12-12
EP06829502A EP1960428B1 (en) 2005-12-12 2006-12-11 Antibodies against amyloid beta with glycosylation in the variable region
PCT/EP2006/011914 WO2007068429A1 (en) 2005-12-12 2006-12-11 Antibodies against amyloid beta 4 with glycosylated in the variable region

Publications (1)

Publication Number Publication Date
SI1960428T1 true SI1960428T1 (sl) 2011-10-28

Family

ID=37745986

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631096T SI1960428T1 (sl) 2005-12-12 2006-12-11 Protitelesa proti amiloidu beta z glikoziliranjem v variabilni regiji

Country Status (34)

Country Link
US (2) US8906370B2 (sl)
EP (2) EP2377886A1 (sl)
JP (1) JP5145241B2 (sl)
KR (2) KR20080077132A (sl)
CN (2) CN102659943B (sl)
AR (1) AR057233A1 (sl)
AT (1) ATE517923T1 (sl)
AU (1) AU2006326301B2 (sl)
BR (1) BRPI0619605B8 (sl)
CA (1) CA2632828C (sl)
CR (1) CR10000A (sl)
CY (1) CY1114783T1 (sl)
DK (1) DK1960428T3 (sl)
DO (1) DOP2006000278A (sl)
EC (1) ECSP088524A (sl)
ES (1) ES2368591T3 (sl)
HK (2) HK1176075A1 (sl)
IL (1) IL191004A (sl)
JO (1) JO2824B1 (sl)
MA (1) MA30038B1 (sl)
MY (1) MY155286A (sl)
NO (1) NO346105B1 (sl)
NZ (1) NZ568241A (sl)
PE (3) PE20100748A1 (sl)
PL (1) PL1960428T3 (sl)
PT (1) PT1960428E (sl)
RS (1) RS52004B (sl)
RU (1) RU2438706C2 (sl)
SI (1) SI1960428T1 (sl)
TW (1) TWI382990B (sl)
UA (1) UA99097C2 (sl)
UY (1) UY30003A1 (sl)
WO (1) WO2007068429A1 (sl)
ZA (1) ZA200805038B (sl)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038568A1 (es) 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
EP1976877B2 (en) 2005-11-30 2016-10-05 AbbVie Inc. Monoclonal antibodies against amyloid beta protein and uses thereof
DK1954718T3 (en) 2005-11-30 2014-12-15 Abbvie Inc Anti-A-globulomer antibodies antigenbindingsgrupper thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods for producing said antibodies,
TWI382990B (zh) * 2005-12-12 2013-01-21 Hoffmann La Roche 可變區域抗體之糖化
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
MX2009006199A (es) * 2006-12-11 2009-06-22 Hoffmann La Roche Formulacion parenteral de anticuerpos abeta.
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
BRPI0813963A2 (pt) 2007-06-29 2015-01-06 Hoffmann La Roche Mutante de cadeia pesada que leva a uma melhor produção de imunoglobulina
KR101637533B1 (ko) * 2007-08-20 2016-07-11 글락소 그룹 리미티드 제조 방법
CA2701793C (en) 2007-10-05 2017-04-25 Genentech, Inc. Use of anti-amyloid beta antibody in ocular diseases
UA101487C2 (en) * 2007-12-21 2013-04-10 Ф. Хоффманн-Ля Рош Аг Humanized b-ly1 antibody formulation
ES2458541T3 (es) * 2008-05-02 2014-05-06 Seattle Genetics, Inc. Métodos y composiciones para elaborar anticuerpos y derivados de anticuerpos con fucosilación del núcleo reducida
WO2010127069A1 (en) * 2009-04-29 2010-11-04 Schering Corporation Antibody purification
WO2011090720A2 (en) * 2009-12-29 2011-07-28 Dr. Reddy's Laboratories Ltd Purification of proteins
PE20130527A1 (es) 2010-03-03 2013-05-09 Boehringer Ingelheim Int Polipeptidos de union a a-beta biparatopicos
CA2796339C (en) 2010-04-15 2020-03-31 Abbott Laboratories Amyloid-beta binding proteins
CN103179981B (zh) 2010-07-30 2017-02-08 Ac免疫有限公司 安全和功能性的人源化抗β‑淀粉样蛋白抗体
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
WO2012142301A2 (en) 2011-04-12 2012-10-18 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
KR102196009B1 (ko) * 2011-10-25 2021-01-04 프로테나 바이오사이언시즈 리미티드 항체 제형 및 방법
CN103998930A (zh) * 2011-12-02 2014-08-20 普拉希京公司 用于形成和检测斑块的斑块阵列方法和组合物
CN104159613B (zh) * 2012-03-08 2016-11-23 霍夫曼-拉罗奇有限公司 Abeta抗体制剂
NZ703585A (en) * 2012-08-29 2018-03-23 Hoffmann La Roche Blood brain barrier shuttle
CN102998454A (zh) * 2012-12-11 2013-03-27 华中师范大学 一种检测生物体内邻苯二甲酸二丁酯相对含量的方法
US9790276B2 (en) 2012-12-18 2017-10-17 The Rockefeller University Glycan-modified anti-CD4 antibodies for HIV prevention and therapy
US9587022B2 (en) 2012-12-18 2017-03-07 The Rockefeller University Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activity
ES2755181T3 (es) 2013-02-13 2020-04-21 Lab Francais Du Fractionnement Anticuerpos anti-TNF-alfa altamente galactosilados y usos de los mismos
JP6169885B2 (ja) 2013-05-07 2017-07-26 株式会社日立製作所 精製装置及び精製方法
KR102571391B1 (ko) 2013-09-13 2023-08-29 제넨테크, 인크. 정제된 재조합 폴리펩티드를 포함하는 방법 및 조성물
PL3044323T3 (pl) 2013-09-13 2022-06-27 F.Hoffmann-La Roche Ag Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych
WO2015075942A1 (ja) 2013-11-22 2015-05-28 国立大学法人 東京大学 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法
WO2015155694A1 (en) 2014-04-08 2015-10-15 Prothena Biosciences Limited Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
WO2015165961A1 (en) 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
EP4074730A1 (en) 2015-06-24 2022-10-19 F. Hoffmann-La Roche AG Anti-transferrin receptor antibodies with tailored affinity
WO2017032686A1 (en) * 2015-08-21 2017-03-02 F. Hoffmann-La Roche Ag Method for the reduction of host cell proteins in affinity chromatography
AR106189A1 (es) * 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
NZ741067A (en) 2015-10-02 2023-07-28 Hoffmann La Roche Bispecific anti-human cd20/human transferrin receptor antibodies and methods of use
HUE057085T2 (hu) * 2015-10-16 2022-04-28 Hoffmann La Roche Egy rendszer mûködtetésére szolgáló eljárás és egy rendszer
EP3374379A4 (en) 2015-11-09 2019-05-15 The University Of British Columbia N-TERMINAL EPITOPES IN BETA-AMYLOID AND CONFORMATIONALLY SELECTIVE ANTIBODIES THEREOF
EP3374381A4 (en) 2015-11-09 2019-05-15 The University Of British Columbia EPITAOPES IN THE CENTRAL REGION OF BETA-AMYLOID AND RELATED CONFORMATIONAL ANTIBODIES
JP7452829B2 (ja) 2015-11-09 2024-03-19 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア アミロイドベータのエピトープおよびそれに対する抗体
US10792477B2 (en) * 2016-02-08 2020-10-06 Orbusneich Medical Pte. Ltd. Drug eluting balloon
EP3427183A1 (en) * 2016-03-10 2019-01-16 Genomic Vision Method of curvilinear signal detection and analysis and associated platform
WO2017189959A1 (en) 2016-04-29 2017-11-02 Voyager Therapeutics, Inc. Compositions for the treatment of disease
TWI735600B (zh) 2016-07-01 2021-08-11 美商美國禮來大藥廠 抗－N3pGlu類澱粉β肽抗體及其用途
US20180125920A1 (en) 2016-11-09 2018-05-10 The University Of British Columbia Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
JPWO2018221244A1 (ja) * 2017-05-30 2019-11-21 森永乳業株式会社 脳機能改善用組成物
CA3070085A1 (en) 2017-07-18 2019-01-24 Promis Neurosciences Inc. Antibodies to amyloid beta
CN108048477A (zh) * 2017-12-15 2018-05-18 南京理工大学 基于大肠杆菌表达系统的制备多肽的方法
EP3778875A1 (en) 2019-08-14 2021-02-17 MaxiVax SA Immortalized myoblast cell lines and uses thereof
EP4185612A1 (en) 2020-07-23 2023-05-31 Othair Prothena Limited Anti-abeta antibodies
AU2021376837A1 (en) 2020-11-16 2023-06-15 F. Hoffmann-La Roche Ag Fab high mannose glycoforms
TW202300517A (zh) 2021-03-12 2023-01-01 美商美國禮來大藥廠 抗類澱粉β抗體及其用途
WO2022251048A1 (en) 2021-05-24 2022-12-01 Eli Lilly And Company Anti-amyloid beta antibodies and uses thereof
CN114591429B (zh) * 2022-05-07 2022-08-09 北京第一生物化学药业有限公司 结合β-淀粉样蛋白的抗体及其用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US5811310A (en) 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
CA1339014C (en) 1987-10-08 1997-03-25 Ronald E. Majocha Antibodies to a4 amyloid peptide
JP2780507B2 (ja) * 1991-03-29 1998-07-30 松下電器産業株式会社 内燃機関用フィルタ再生装置
US5955317A (en) * 1993-01-25 1999-09-21 Takeda Chemical Industries, Ltd. Antibodies to β-amyloids or their derivatives and use thereof
EP0683234B2 (en) 1993-01-25 2007-06-06 Takeda Chemical Industries, Ltd. Antibody against beta-amyloid or their derivative and use thereof
US5443953A (en) * 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
GB9416007D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Anthracyclinone derivatives
US5688651A (en) * 1994-12-16 1997-11-18 Ramot University Authority For Applied Research And Development Ltd. Prevention of protein aggregation
CA2222522A1 (en) * 1995-06-06 1996-12-12 Stemcell Therapeutics L.L.C. Glycoprotein gp105 on bl3 hematopoietic stem cells
DE69621940T2 (de) 1995-08-18 2003-01-16 Morphosys Ag Protein-/(poly)peptidbibliotheken
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
DE60035412T2 (de) * 1999-03-04 2008-02-14 Praecis Pharmaceuticals, Inc., Cambridge Beta-amyloid-peptidaggregation regulierende peptide mit d-aminosäuren
US6582945B1 (en) 1999-06-16 2003-06-24 Boston Biomedical Research Institute Immunological control of β-amyloid levels in vivo
AU6722300A (en) 1999-08-31 2001-03-26 Ramot University Authority For Applied Research And Industrial Development Ltd. Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders
US20020094335A1 (en) 1999-11-29 2002-07-18 Robert Chalifour Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
AU784312B2 (en) 1999-11-29 2006-03-09 Bellus Health (International) Limited Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
EP1125905A1 (en) 2000-02-16 2001-08-22 Pepscan Systems B.V. Segment synthesis
CZ306683B6 (cs) 2000-02-24 2017-05-03 Washington University Léčivo pro prevenci nebo léčení preklinické nebo klinické Alzheimerovy nemoci
CA2313828A1 (en) 2000-08-01 2002-02-01 Institut De Recherches Cliniques De Montreal/Ircm Post-translational processing of .beta.-secretase (bace): the pro-and transmembrane/cytosolic domains affect its cellular activity and amyloid a.beta. production
PE20020574A1 (es) 2000-12-06 2002-07-02 Wyeth Corp Anticuerpos humanizados que reconocen el peptido amiloideo beta
WO2002064734A2 (en) 2000-12-19 2002-08-22 Palatin Technologies, Inc. Identification of target-specific folding sites in peptides and proteins
WO2002088307A2 (en) 2001-04-30 2002-11-07 Eli Lilly And Company Humanized antibodies
EP1385545B1 (en) 2001-04-30 2009-01-07 Eli Lilly And Company Humanized antibodies recognizing the beta-amyloid peptide
US20040192898A1 (en) * 2001-08-17 2004-09-30 Jia Audrey Yunhua Anti-abeta antibodies
US7771722B2 (en) * 2001-08-17 2010-08-10 Eli Lilly And Company Assay method for alzheimer's disease
AR038568A1 (es) * 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
MY139983A (en) * 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
US20040146512A1 (en) 2002-10-09 2004-07-29 Arnon Rosenthal Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
DE10303974A1 (de) * 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
TWI382990B (zh) * 2005-12-12 2013-01-21 Hoffmann La Roche 可變區域抗體之糖化
MX2009006199A (es) * 2006-12-11 2009-06-22 Hoffmann La Roche Formulacion parenteral de anticuerpos abeta.

Also Published As

Publication number Publication date
PL1960428T3 (pl) 2012-02-29
CA2632828C (en) 2012-07-10
JO2824B1 (en) 2014-09-15
MA30038B1 (fr) 2008-12-01
ATE517923T1 (de) 2011-08-15
UY30003A1 (es) 2007-08-31
CN101351476A (zh) 2009-01-21
EP1960428B1 (en) 2011-07-27
UA99097C2 (ru) 2012-07-25
ES2368591T3 (es) 2011-11-18
US8906370B2 (en) 2014-12-09
AU2006326301B2 (en) 2011-04-21
JP2009520691A (ja) 2009-05-28
ECSP088524A (es) 2008-07-30
US9272031B2 (en) 2016-03-01
JP5145241B2 (ja) 2013-02-13
ZA200805038B (en) 2009-06-24
CN102659943A (zh) 2012-09-12
EP2377886A1 (en) 2011-10-19
KR20120089483A (ko) 2012-08-10
DK1960428T3 (da) 2011-08-22
DOP2006000278A (es) 2007-07-15
EP1960428A1 (en) 2008-08-27
BRPI0619605B1 (pt) 2019-08-13
CN101351476B (zh) 2013-04-03
PT1960428E (pt) 2011-10-07
AR057233A1 (es) 2007-11-21
NO20082874L (no) 2008-08-28
TWI382990B (zh) 2013-01-21
US20150165022A1 (en) 2015-06-18
BRPI0619605B8 (pt) 2021-05-25
HK1176075A1 (en) 2013-07-19
IL191004A (en) 2013-08-29
PE20100748A1 (es) 2010-11-12
BRPI0619605A2 (pt) 2011-10-11
PE20071002A1 (es) 2007-11-19
KR20080077132A (ko) 2008-08-21
TW200736273A (en) 2007-10-01
MY155286A (en) 2015-09-30
BRPI0619605A8 (pt) 2019-01-15
CA2632828A1 (en) 2007-06-21
PE20100684A1 (es) 2010-10-04
CN102659943B (zh) 2015-07-01
NO346105B1 (no) 2022-02-21
RU2008128138A (ru) 2010-01-20
HK1130066A1 (en) 2009-12-18
NZ568241A (en) 2011-08-26
WO2007068429A1 (en) 2007-06-21
US20090252724A1 (en) 2009-10-08
CY1114783T1 (el) 2016-12-14
CR10000A (es) 2008-07-29
KR101401159B1 (ko) 2014-05-29
RS52004B (en) 2012-04-30
RU2438706C2 (ru) 2012-01-10
AU2006326301A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
PT1960428E (pt) Anticorpos glicosilados na região variável contra beta-amilóide 4
IL289365A (en) Monoclonal antibodies against amyloid beta protein and uses thereof
EP1851245A4 (en) ANTIBODIES DIRECTED AGAINST INTERLEUKIN-1 BETA
IL237167A0 (en) Monoclonal antibodies selective for expressing amyloid, preparations, mixtures and their use
IL205127A (en) Antibody to aβ is humanized, a preparation containing it and its uses
PL2468770T3 (pl) Humanizowane przeciwciało przeciw amyloidowi beta
PL2074145T3 (pl) Humanizowane przeciwciało przeciw amyloidowi beta
LT2842967T (lt) Beta amiloido pegilintas fab
SI2379601T1 (sl) Anti-idiotipsko protitelo proti protitelesu proti amiloid beta peptidu
IL187316A0 (en) Anti-interleukin 2 antibodies
IL186500A0 (en) Protein glycosylation
IL254065B (en) Human antibody against amyloid in the cell
ME01826B (me) MONOKLONALNA ANTITELA PROTIV AMILOIDNOG BETA PROTEINA l NJIHOVA UPOTREBA
GB0524263D0 (en) The anti fod device
SI1976877T2 (sl) Monoklonska protitelesa proti amiloidnemu beta proteinu in njihove uporabe
GB0517560D0 (en) Sandwich transporter
PL376079A1 (pl) Piec akumulacyjny obiektu
GB0516424D0 (en) Improvement in the lamp
GB0506773D0 (en) The aero bin